Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)

Descourt R, Guisier F, Pérol M, Cadranel J, Doubre H, Duruisseaux M, Culine S, Mennecier B, Bylicki O, Chouaid C, Greillier L

Lung Cancer: Targets and Therapy 2025, 16:107-114

Published Date: 12 August 2025